Multicell Techs Company Insiders
Multicell Techs employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 18 years, averaging almost 9.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Multicell Techs' management performance can provide insight into the firm performance.
| Gerald Newmin Chairman Chairman, CEO and President CFO, Treasurer and Secretary |
Multicell |
Multicell Techs Management Team Effectiveness
The company has return on total asset (ROA) of (1.3637) % which means that it has lost $1.3637 on every $100 spent on assets. This is way below average. Multicell Techs' management efficiency ratios could be used to measure how well Multicell Techs manages its routine affairs as well as how well it operates its assets and liabilities.Multicell Techs Workforce Comparison
Multicell Techs is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 474. Multicell Techs adds roughly 2.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6. Multicell Techs Benchmark Summation
Operator |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Multicell Techs Price Series Summation is a cross summation of Multicell Techs price series and its benchmark/peer.
Multicell Techs Notable Stakeholders
A Multicell Techs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Multicell Techs often face trade-offs trying to please all of them. Multicell Techs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Multicell Techs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Gerald Newmin | Chairman, CEO and President CFO, Treasurer and Secretary | Profile | |
| Barbara Corbett | Manager of Investor Relations | Profile |
About Multicell Techs Management Performance
The success or failure of an entity such as Multicell Techs often depends on how effective the management is. Multicell Techs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Multicell management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Multicell management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island. Multicell Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Please note, the imprecision that can be found in Multicell Techs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Multicell Techs. Check Multicell Techs' Beneish M Score to see the likelihood of Multicell Techs' management manipulating its earnings.
Multicell Techs Workforce Analysis
Traditionally, organizations such as Multicell Techs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Multicell Techs within its industry.Multicell Techs Manpower Efficiency
Return on Multicell Techs Manpower
| Revenue Per Employee | 24.7K | |
| Revenue Per Executive | 24.7K | |
| Net Loss Per Employee | 190K | |
| Net Loss Per Executive | 190K |
Additional Tools for Multicell Pink Sheet Analysis
When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.